Fios Genomics at the 4th Annual Drug Discovery USA Congress
- 16th August 2017
- Posted by: Claudine Gabriele
- Category: Uncategorised
The Drug Discovery USA Congress returns for its 4th time at Hilton San Diego Mission Valley Hotel, co-located with the 2nd Annual Biomarkers & Precision Medicine Congress.
Presentations and panels will highlight the latest advances in preclinical and clinical biomarker research strategies in various therapeutic areas.
The biopharma industry has been challenged with high costs and protracted times in drug development processes. As our clients are involved in drug discovery and development, at Fios Genomics we are always keen in knowing more about the most recent key approaches for improving efficacy and cost-effectiveness of drugs in the biopharmaceutical sector.
On this front, the congress will highlight innovative strategies that are recently being used for target validation, latest screening paradigms, essential activities in therapeutic areas such as oncology and neuroscience.
Other topics that will be covered are:
- Application of artificial intelligence for drug discovery.
- Latest trends in computational chemistry, data analytics and computer-aided drug design.
- DNA-encoded libraries.
- Phenotypic drug discovery, high-throughput technologies and RNAi screening.
Where and when
Our team will be attending both days of the event (9-10 October): we will be exhibiting at in the Cortez Ballroom and Foyer so make sure to come along at our booth and have a chat with us!